VACCINE COMPOSITIONS AND THEIR USE

The invention relates to immunogenic compositions and their use as a vaccine for the prevention of coronavirus disease in a human subject. More specifically, the invention relates to methods of use of an immunogenic composition in the prevention of coronavirus disease in a human subject in need ther...

Full description

Saved in:
Bibliographic Details
Main Authors GUYON-GELLIN, DELPHINE, HALLER, MARJORIE, LE VERT, ALEXANDRE, NICOLAS, FLORENCE
Format Patent
LanguageEnglish
French
Published 29.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to immunogenic compositions and their use as a vaccine for the prevention of coronavirus disease in a human subject. More specifically, the invention relates to methods of use of an immunogenic composition in the prevention of coronavirus disease in a human subject in need thereof, said immunogenic composition comprising: a fusion protein comprising (i) a SARS-Cov2 nucleocapsid N antigen and, (ii) a carrier protein comprising a self-assembling polypeptide derived from C4bp oligomerization domain and a positively charged tail. L'invention concerne des compositions immunogènes et l'utilisation de celles-ci en tant que vaccin pour la prévention de la maladie à coronavirus chez un sujet humain. Plus spécifiquement, l'invention concerne des méthodes d'utilisation d'une composition immunogène dans la prévention de la maladie à coronavirus chez un sujet humain en ayant besoin, ladite composition immunogène comprenant : une protéine de fusion comprenant (i) un antigène N de nucléocapside du SARS-Cov2 et (ii) une protéine porteuse comprenant un polypeptide à auto-assemblage, dérivé du domaine d'oligomérisation C4bp, et une queue chargée positivement.
Bibliography:Application Number: CA20223242433